<DOC>
	<DOCNO>NCT01885091</DOCNO>
	<brief_summary>The purpose K.I.S.S . study evaluate efficacy Kinerase® Cream ( Kinetin 0.1 % ) Thai patient , basis severity clinical sign facial photodamage .</brief_summary>
	<brief_title>Efficacy Safety Study Kinerase® Treatment Cutaneous Facial Photodamage</brief_title>
	<detailed_description />
	<mesh_term>Kinetin</mesh_term>
	<criteria>1 . Male female subject older 35 year age less 65 year age . 2 . Subjects mild , moderate severe facial photodamage assess 10point scale . 3 . Subjects willing sign inform consent adhere protocol requirement . 1 . Male female subject suspect porphyria , systemic cutaneous erythematosus lupus , photosensitize disorder druginduced photosensitization . 2 . Subjects chronic recur skin disease disorder . 3 . Subjects active infectious skin disorder ( Herpes simplex , molluscum contagiosum , facial wart ) . 4 . Subjects skin cancer facial tissue . 5 . Subjects receive laser/ intense pulse light ( IPL ) / chemical peel 2 month precede screen visit . 6 . Subjects history topical and/or oral isotretinoin use , 6 month prior screen visit . 7 . Subjects topical RetinA Renova 2 month prior screen visit . 8 . Subjects use topical alphahydroxy acid skin care product month precede screen visit . 9 . Subjects currently antiaging product wish continue use product . 10 . Subjects require concurrent treatment would interfere study assessment . 11 . Pregnant lactate female subject .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>